CoChat

Neonatal S100B Protein Levels After Prenatal Exposure to Selective Serotonin Reuptake Inhibitors

Pawluski, Jodi L., Galea, Liisa A.M., Brain, Ursula, Papsdorf, Michael, Oberlander, Tim F. · 2009 · Pediatrics

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: This study investigated neonatal S100B levels as a biomarker of prenatal selective serotonin reuptake inhibitor (SSRI) exposure. METHODS: Maternal (delivery; N = 53) and neonatal (cord; N = 52) serum S100B levels were compared between prenatally SSRI-exposed (maternal, N = 36; neonatal, N = 37; duration: 230 ± 71 days) and nonexposed (maternal, N = 17; neonatal, N = 15) groups. Measures of maternal depression and anxiety symptoms were assessed during the third trimester (33–36 weeks), and neonatal outcomes, including Apgar scores, birth weight, gestational age at birth, and symptoms of poor neonatal adaptation, were recorded. RESULTS: S100B levels were significantly lower in prenatally SSRI-exposed neonates than in nonexposed neonates, controlling for gestational age and third-trimester maternal mood (P = .036). In contrast, SSRI-exposed mothers had significantly higher maternal serum S100B levels, compared with nonexposed mothers (P = .014), even controlling for maternal mood in the third trimester. S100B levels were not associated with maternal or neonatal drug levels, duration of prenatal exposure, demographic variables, or risk for poor neonatal adaptation. CONCLUSIONS: Prenatal SSRI exposure was associated with decreased neonatal serum S100B levels, controlling for prenatal maternal mood. Neonatal S100B levels did not reflect neonatal behavioral outcomes and were not related to pharmacologic indices. These findings are consistent with prenatal alcohol and cocaine exposures, which also alter central serotonin levels.

Overview

Integrity signals

Registry

Crossref · 10.1542/peds.2009-0442

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 65 references

Cited by

See all 65

Metadata

Authors
Pawluski, J. L., Galea, L. A. M., Brain, U., Papsdorf, M., & Oberlander, T. F.
Affiliations
  • Departments of Pediatrics
  • University of British Columbia (CA)
  • BC Children's Hospital (CA)
Venue
Pediatrics
Published
2009-10-01
Volume
124
Issue
4
Pages
e662-e670
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
OpenAlex
W2130914256
Cited by
65
References
65
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 7 · 2013: 7 · 2012: 4
FWCI
6.02
Type
journal article
Language
en
Open access
closed
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
S100B, selective serotonin reuptake inhibitors, prenatal drug exposure, neonatal biomarkers, maternal depression, maternal anxiety, neonatal adaptation, cord serum, maternal serum, serotonin
MeSH terms
Analysis of Variance, Depressive Disorder, Female, Fetal Blood, Humans, Infant, Newborn, Longitudinal Studies, Male, Maternal-Fetal Exchange, Nerve Growth Factors, S100 Proteins, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Pregnancy Trimester, Second, Prenatal Diagnosis, Prenatal Exposure Delayed Effects, Probability, Prospective Studies, Biomarkers, Confidence Intervals, Selective Serotonin Reuptake Inhibitors, Risk Assessment, Maternal Exposure, S100 Calcium Binding Protein beta Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neonatal S100B Protein Levels After Prenatal Exposure to Selective Serotonin Reuptake Inhibitors. https://app.cochat.ai/papers/10.1542/peds.2009-0442
The paper
Pawluski, J. L., Galea, L. A. M., Brain, U., Papsdorf, M., & Oberlander, T. F. (2009). Neonatal S100B Protein Levels After Prenatal Exposure to Selective Serotonin Reuptake Inhibitors. Pediatrics. https://doi.org/10.1542/peds.2009-0442

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.